PAR · ALMDT.PA
Median Technologies S.A.
€4.26-€0.12 (-2.63%)
Median Technologies S.A.’s quoted price sits in the lower half of its reported 52-week range, 41.47% below the high.
Loading market information…
PAR · ALKLH.PA · EUR
Stock price, earnings
Quote as of Oct 29, 2026, 04:35 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
Klea Holding’s quoted price sits in the lower half of its reported 52-week range, 38.42% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Klea Holding’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Klea Holding SA, along with its subsidiaries, provides healthcare technology solutions and related services across France and internationally. The company's key offerings include BewellConnect, a comprehensive health ecosystem that facilitates augmented and assisted teleconsultation, remote patient monitoring for both home and hospital settings, tele-expertise, virtual assistance, and remote regulatory services. Additionally, Klea Holding SA markets Smart Salem, a specialized device for medical fitness assessments. Founded in 2007 and headquartered in Paris, France, the company operated under the name Visiomed Group SA until it rebranded to Klea Holding SA in June 2024.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:31 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
€4.26-€0.12 (-2.63%)
Median Technologies S.A.’s quoted price sits in the lower half of its reported 52-week range, 41.47% below the high.
€2.81€0.00 (0.0%)
Affluent Medical S.A.’s quoted price sits in the upper half of its reported 52-week range, 4.75% below the high.
€16,100.00€0.00 (0.0%)
Eurofins-Cerep S.A.’s quoted price sits in the lower half of its reported 52-week range, 21.84% below the high.
€1.27+€0.02 (+1.59%)
Crossject S.A.’s quoted price sits in the lower half of its reported 52-week range, 52.81% below the high.
€8.90+€0.10 (+1.14%)
Sensorion S.A.’s quoted price sits in the lower half of its reported 52-week range, 77.97% below the high.
€0.39-€0.00 (-0.13%)
Fermentalg’s quoted price sits in the lower half of its reported 52-week range, 39.14% below the high.
€0.55+€0.01 (+1.11%)
AB Science S.A.’s quoted price sits in the lower half of its reported 52-week range, 65.96% below the high.
€0.45+€0.01 (+1.37%)
Novacyt S.A.’s quoted price sits in the lower half of its reported 52-week range, 57.21% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
